The psr-1 antibody specifically detects the Caenorhabditis elegans PSR-1 protein, a type II transmembrane receptor involved in recognizing phosphatidylserine (PS) exposed on apoptotic cells. PSR-1 facilitates phagocytosis through its extracellular lysine-rich PS-binding motif and interacts with downstream signaling components like CED-2, CED-5, and CED-12 .
PS-Binding Motif: Mutagenesis studies using psr-1 antibodies identified a lysine-rich motif (K305, K308, K315, K319) critical for PS binding. Substitutions (e.g., K308E/K315E) abolished PS recognition .
Oligomerization: Antibody-based assays revealed PS-induced oligomerization of PSR-1, a mechanism for phagocytosis activation .
Functional Redundancy: PSR-1 works redundantly with other receptors (e.g., CED-1) but is indispensable for clearing necrotic cells and apoptotic germ cells .
Membrane Topology: Immunostaining with psr-1 antibodies confirmed PSR-1’s type II transmembrane structure, with its N-terminus cytosolic and C-terminus extracellular .
Clustering Around Apoptotic Cells: Live-cell imaging showed PSR-1 enrichment around apoptotic germ cells, forming punctate structures akin to CED-1 phagocytic receptors .
Mutations in the Fe(II)-binding JmjC domain (critical for histone demethylase activity) did not impair phagocytosis, confirming that PSR-1’s primary role is PS recognition .
Low Protein Abundance: PSR-1 is expressed at extremely low levels in C. elegans, requiring ultrasensitive detection methods (e.g., 3xFlag-tagged transgenes) .
Cross-Reactivity: Some antibodies cross-react with human JMJD6, necessitating validation in species-specific models .
STRING: 6239.F29B9.4a.1
UniGene: Cel.34934
PSR-1 is a conserved phosphatidylserine receptor with a critical role in recognizing the "eat-me" signal on apoptotic cells. It contains a lysine-rich motif in its extracellular domain that mediates specific phosphatidylserine binding in vitro and clearance of apoptotic cells in vivo. PSR-1 is particularly important for understanding fundamental cellular processes including phagocytosis and cell clearance mechanisms. Research has established PSR-1 as a phosphatidylserine-recognizing phagocyte receptor that forms oligomers upon binding to phosphatidylserine on apoptotic cells, activating downstream signaling pathways necessary for engulfment .
According to research literature, multiple antibodies have been developed against PSR-1. Researchers have generated at least 13 mouse monoclonal antibodies and 8 rat polyclonal antibodies against PSR-1. While these antibodies demonstrate high affinity to recombinant PSR-1 proteins, they face significant challenges in detecting endogenous PSR-1 in worm lysates by immunoblotting or in animals by immunostaining, suggesting extremely low expression levels or protein instability in vivo .
The primary challenge in PSR-1 detection is its remarkably low endogenous expression level. Real-time RT-PCR analysis indicates that PSR-1 mRNA levels are approximately 1/4 of the ced-1 gene and 1/100 of the housekeeping gene rpl-26. Additionally, PSR-1 may be unstable in vivo, further complicating detection. Even with 21 different antibodies showing high affinity to recombinant PSR-1, researchers were unable to detect endogenous PSR-1, requiring the use of epitope-tagging strategies with ultrasensitive tags like 3xFlag to achieve detection .
For successful PSR-1 detection in C. elegans, consider the following methodological approaches:
Epitope tagging strategy: Generate single-copy insertions (SCIs) of PSR-1 with sensitive epitope tags like 3xFlag, which enables detection of femtomole levels of tagged protein. This approach has been validated in research where a 3xFlag epitope attached to PSR-1 allowed detection by immunoblotting when conventional antibodies failed .
Tissue-specific focus: Target detection efforts on tissues known to express PSR-1, such as gonadal sheath cells in C. elegans, which serve as phagocytes to remove apoptotic germ cells .
Enhanced detection methods: Use highly sensitive detection systems for immunoblotting, with longer exposure times and signal amplification techniques.
Specific experimental conditions: Look for PSR-1 enrichment around apoptotic cells, where the protein concentrates and forms a punctate circle pattern, making detection more feasible compared to general tissue staining .
Membrane topology considerations: When designing immunostaining experiments, consider PSR-1's membrane topology with its N-terminus in the cytoplasm and C-terminus in the extracellular space, which affects antibody accessibility under different permeabilization conditions .
Robust validation of PSR-1 antibody specificity is critical for reliable experimental outcomes:
Genetic validation: Test antibodies on psr-1 null mutants (such as psr-1(tm469)) to confirm specificity and absence of non-specific signals .
Recombinant protein controls: Use purified recombinant PSR-1 as a positive control to establish detection limits and antibody performance .
Tagged PSR-1 expression: Utilize single-copy insertion transgenes expressing tagged versions (e.g., 3xFlag-PSR-1 or PSR-1-3xFlag) for comparison with antibody detection .
Western blot analysis: Verify the presence of a specific band at the appropriate molecular weight (reported as slightly larger than 50 kD for 3xFlag-PSR-1) and assess non-specific bands in test and control samples .
Multiple detection methods: Compare results from different techniques like immunoblotting and immunostaining to build confidence in antibody performance.
| Validation Method | Approach | Expected Outcome |
|---|---|---|
| Genetic | Compare wild-type vs. psr-1(tm469) | Signal present only in wild-type |
| Recombinant protein | Dilution series of purified PSR-1 | Concentration-dependent signal |
| Tagged constructs | 3xFlag::PSR-1 SCI expression | Consistent detection with anti-PSR-1 and anti-Flag |
| Mutation analysis | K308E/K315E or H192A/D194A mutations | Similar protein levels but altered function |
| Cross-reactivity assessment | Testing in multiple species/tissues | Specific binding pattern matching known expression |
When investigating PSR-1 subcellular localization, researchers should consider:
Predicted membrane topology: PSR-1 is a type II transmembrane protein with its N-terminus in the cytoplasm and C-terminus in the extracellular space. This topology has been experimentally confirmed using differentially tagged constructs (3xFlag::PSR-1 SCI and PSR-1::3xFlag SCI) under permeabilized versus non-permeabilized conditions .
Dynamic localization patterns: PSR-1 enriches and clusters around apoptotic cells during apoptosis, forming a punctate circle similar to that formed by the CED-1 phagocyte receptor. This pattern is transient and may be missed without careful temporal analysis .
Tissue-specific expression: PSR-1 acts in specific phagocytic cells, such as gonadal sheath cells in C. elegans, which remove apoptotic germ cells. Expression of PSR-1 in these cells, but not in germ cells themselves, is sufficient for rescue of engulfment defects .
Low abundance considerations: The extremely low expression level of PSR-1 means it may only become detectable when concentrated around apoptotic cells, making general tissue staining challenging .
Research indicates that PSR-1 undergoes phosphatidylserine-induced oligomerization, which is likely a mechanism for activating phagocytosis. To study this process:
Use the phosphatidylserine-binding motif: The lysine-rich motif in PSR-1's extracellular domain mediates both phosphatidylserine binding and phosphatidylserine-induced oligomerization. This motif can be targeted for mutational analysis to dissect oligomerization mechanisms .
Generate point mutations: Create specific mutations in the phosphatidylserine-binding motif (e.g., K308E/K315E) to disrupt oligomerization while maintaining protein stability. Research confirms these mutations abolish PSR-1 phagocytic function while maintaining normal protein expression levels .
Monitor clustering in vivo: Examine PSR-1 enrichment and clustering around apoptotic cells during apoptosis using tagged PSR-1 constructs. The punctate circle pattern observed around apoptotic cells provides a readout for functional oligomerization .
Compare with other phagocytic receptors: Analyze PSR-1 clustering in relation to other engulfment receptors like CED-1, which shows similar punctate circles around apoptotic cells .
PSR-1 has been suggested to have multiple biochemical activities, including potential roles as an arginine demethylase, a lysyl hydroxylase, or an RNA binding protein through its N-terminal JmjC domain. To distinguish between these activities:
Use domain-specific mutations: Generate mutations in:
The Fe(II) binding site (e.g., H192A/D194A) to disrupt JmjC domain activity
The phosphatidylserine-binding motif (e.g., K308E/K315E) to impair phosphatidylserine binding
Conduct functional rescue experiments: Research shows that mutations in the phosphatidylserine-binding motif, but not in the Fe(II) binding site critical for JmjC activity, abolish PSR-1 phagocytic function, indicating that phosphatidylserine binding rather than JmjC activity is essential for cell clearance .
Verify protein expression: Confirm that domain-specific mutations do not affect protein stability or expression levels. Western blot analysis in research has confirmed comparable PSR-1 protein levels in wild-type and mutant constructs .
Analyze phenotypic outcomes: Compare phenotypes between wild-type, JmjC domain mutants, and PS-binding motif mutants to determine which functions are relevant in specific biological contexts.
Understanding PSR-1's downstream signaling requires specialized approaches:
Analyze genetic interactions: Research suggests PSR-1 triggers phagocytosis by recruiting the CED-2/CED-5/CED-12 ternary signaling complex. Testing genetic interactions between psr-1 and components of this pathway can elucidate signaling mechanisms .
Study PSR-1 clustering dynamics: The phosphatidylserine-induced oligomerization of PSR-1 likely serves as a mechanism to initiate signaling. Analyzing clustering patterns and their correlation with downstream events can illuminate signaling activation .
Examine engulfment kinetics: Compare the rate and efficiency of apoptotic cell clearance between wild-type animals and those expressing mutant forms of PSR-1 to assess signaling consequences.
Investigate tissue-specific effects: Express PSR-1 in specific phagocytic cells, such as gonadal sheath cells, to determine where signaling occurs. Research confirms PSR-1 acts cell-autonomously in phagocytes rather than in dying cells .
When encountering negative results with PSR-1 antibodies:
Consider expression levels: PSR-1 is expressed at extremely low levels, with mRNA approximately 1/4 of ced-1 and 1/100 of rpl-26. Negative immunostaining or immunoblotting may reflect genuine low abundance rather than technical failure .
Evaluate protein stability: Research suggests PSR-1 may be unstable in vivo, potentially explaining detection difficulties even with multiple high-affinity antibodies .
Examine temporal dynamics: PSR-1 may transiently appear on phagocyte surfaces during apoptotic cell clearance. Negative results might reflect missing this narrow temporal window .
Focus on enrichment sites: PSR-1 concentrates around apoptotic cells, forming detectable clusters while general tissue staining remains negative. Target detection efforts on regions surrounding apoptotic cells .
Consider alternative approaches: Use epitope tagging strategies with ultrasensitive tags like 3xFlag, which has proven successful when conventional antibodies fail .
Researchers should be aware of these common technical challenges:
Low signal-to-noise ratio: Due to PSR-1's low expression, distinguishing specific signals from background can be difficult. In research, even 21 different antibodies with high affinity to recombinant PSR-1 failed to detect endogenous protein .
Permeabilization conditions: Incorrect permeabilization can affect epitope accessibility. Research demonstrated different results with permeabilized versus non-permeabilized conditions when studying PSR-1's membrane topology .
Transient expression patterns: PSR-1 may appear transiently during specific cellular processes, similar to human PSR which transiently appears on THP-1 phagocytes after PMA activation .
Expression system artifacts: Overexpression systems may not reflect endogenous behavior. The use of single-copy insertion technology helps avoid overexpression artifacts .
Cross-reactivity issues: Antibodies may detect non-specific proteins, as observed in research where an additional band of lower molecular weight was detected in both wild-type and transgenic animals .
When integrating PSR-1 research with other phosphatidylserine receptors:
Compare membrane topology: PSR-1 is a type II transmembrane protein with its N-terminus in the cytoplasm and C-terminus in the extracellular space. Compare this topology with other phosphatidylserine receptors to understand structural similarities and differences .
Analyze phosphatidylserine-binding mechanisms: The lysine-rich motif in PSR-1's extracellular domain mediates phosphatidylserine binding. Compare this with binding mechanisms of other receptors to identify conserved principles .
Examine signaling pathway overlap: PSR-1 recruits the CED-2/CED-5/CED-12 ternary complex. Determine if other phosphatidylserine receptors engage the same or different signaling pathways .
Study receptor-specific versus redundant functions: Compare phenotypes of single and multiple receptor mutants to determine unique and overlapping functions.
Investigate receptor cooperation: Different phosphatidylserine receptors may work together during apoptotic cell clearance. Study potential cooperative interactions through co-localization and functional analysis.
Comparative analysis between species reveals:
Conservation of phosphatidylserine binding: The phosphatidylserine-binding function of PSR-1 appears conserved across species. In both C. elegans and human cells, PSR localizes to the cell surface of phagocytes and is important for engulfment of apoptotic cells .
Subcellular localization differences: Human PSR has been reported to localize to plasma membrane, nuclei, or both, while C. elegans PSR-1 appears primarily at the plasma membrane with enrichment around apoptotic cells .
Cross-species functional parallels: The transient appearance of human PSR on THP-1 phagocytes after activation parallels the transient clustering of C. elegans PSR-1 around apoptotic cells, suggesting conserved regulatory mechanisms .
Diverse functions across species: In Chlamydomonas reinhardtii, PSR1 influences phosphate uptake and metabolism, suggesting species-specific adaptations of PSR proteins for different biological functions .
When investigating PSR-1's role in phosphate metabolism:
Analyze expression correlation: In Chlamydomonas reinhardtii, PSR1 overexpression affects both transgene and endogenous gene expression levels, which correlate with changes in phosphate uptake rates. Consider similar mutual regulation in other systems .
Examine temporal dynamics: The timing of PSR1 expression changes relative to phosphate uptake responses provides insights into causality. In Chlamydomonas, the strongest PSR1-overexpressing line showed early increases in both endogenous PSR1 and transgene expression, correlating with early phosphate uptake responses .
Consider protein-mRNA level correlations: YFP antibody signals matched transgene mRNA levels in Chlamydomonas studies, indicating direct relationship between transcription and protein expression .
Evaluate similarities to stress responses: Gene regulation patterns associated with increased phosphate uptake by PSR1 overexpression may resemble those of phosphate starvation responses, particularly for gene induction rather than repression .
Analyze functional gene groups: PSR1 overexpression affects genes involved in phosphate transport (e.g., PTB2-4, PTA1) even when external phosphate levels are high, suggesting direct regulatory roles independent of environmental phosphate status .
| PSR1 Expression Level | P-uptake Response Timing | Endogenous PSR1 Induction | Key Regulated Genes |
|---|---|---|---|
| Strong (Line 8-27) | Early response | 10-fold increase (d3) | Phosphate transporters, MEKK |
| Moderate (Line 8-42) | Later response | 3-fold increase (constant) | Similar genes, delayed induction |
| Control (UVM4) | Baseline | Reference level | Minimal induction |